Vice President, Global Scientific Communications

Position Summary

Alnylam Pharmaceuticals is seeking an accomplished and visionary Vice President, Global Scientific Communications to lead the strategic development and execution of global scientific communication activities across our portfolio including the ATTR franchise and pipeline assets. Reporting directly to the Sr. Vice President, Head of Medical Affairs, this executive leader will oversee Medical Communications & Publications, Medical Information & Review, Medical Training, and the office of Grants and Sponsor ships.

They will play a critical role in advancing Alnylam's scientific leadership and reputation among healthcare professionals, researchers, and patient communities. The successful candidate will be a highly strategic, scientifically sophisticated leader with extensive experience developing and executing integrated medical communication and publication strategies in support of innovative therapies. This individual will partner closely with Clinical Development, Commercial, Regulatory, and Corporate Communications teams to ensure the timely dissemination of high-quality scientific evidence about our products that supports patient care and advances the understanding of disease and treatment.

• Develop and execute the long term integrated global strategy for Medical Communications, Publications, and Medical Information aligned with Alnylam's corporate and Medical Affairs objectives.
• Partner as a key member of the Medical Affairs Leadership Team to define strategy and drive organizational development.
• Build and retain a best-in-class scientific communications organization recognized for innovation, excellence, compliance, and scientific rigor.
• Interact with key societies and organizations related to publications and congresses
• Establish and chair publication governance structures and publication committees.
• Drive innovation in scientific engagement, digital communications, and omnichannel medical education approaches.
• Act as a senior scientific representative and thought leader to key external stakeholders.
• Foster a culture of scientific excellence, accountability, innovation, collaboration, and continuous learning.
• Build organizational capabilities to support Alnylam's continued growth and expanding portfolio.

• Advanced scientific or clinical degree (MD, PharmD, PhD, or equivalent).
• Minimum of 15 years of progressive experience in Medical Communications, Publications, Medical Affairs, Scientific Communications, or related functions within the pharmaceutical or biotechnology industry.
• Significant people leadership experience, including management of large, complex, and geographically dispersed teams.
• Demonstrated success developing and executing global publication and scientific communication strategies.
• Extensive experience leading publication planning, publication committees, and scientific dissemination activities.
• Proven expertise in engagement with key opinion leaders, academic investigators, and professional societies.
• Deep understanding of ICMJE, GPP, publication ethics, authorship standards, and industry regulations.
• Significant experience planning and leading major international scientific congresses.
• Strong executive presence and exceptional communication, collaboration, and influencing skills.

• Experience with in rare disease, specialty medicine, cardiovascular, neurology, or RNAi therapeutics.
• Demonstrated success building and transforming high-performing scientific communications organizations.
• Experience interacting with journal editors, editorial boards, and leading scientific publications.
• Global experience supporting multiple regions and cross-functional teams.

$ - $ The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam’s robust Total Rewards package is designed to support your…